tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLRB Stock Latest News

Cellectar Biosciences Approves Reverse Stock Split Proposal
Company AnnouncementsCellectar Biosciences Approves Reverse Stock Split Proposal
4d ago
8K
CLRB
Cellectar Biosciences provides update on CLOVER-2 Phase 1 trial
PremiumThe Fly
Cellectar Biosciences provides update on CLOVER-2 Phase 1 trial
6d ago
CLRB
Cellectar Biosciences Raises $2.5 Million via Stock Sale
PremiumCompany Announcements
Cellectar Biosciences Raises $2.5 Million via Stock Sale
12d ago
8K
CLRB
Cellectar Biosciences enters common stock agreements to raise $2.5M
PremiumThe Fly
Cellectar Biosciences enters common stock agreements to raise $2.5M
12d ago
CLRB
3 Penny Stocks to Watch Now, 6/5/25
PremiumMarket News
3 Penny Stocks to Watch Now, 6/5/25
12d ago
KWM
BAOS
Roth says FDA decision can help Cellectar partner, sell iopofosine I 131
PremiumThe FlyRoth says FDA decision can help Cellectar partner, sell iopofosine I 131
13d ago
CLRB
Cellectar announces U.S. FDA granted BTD for iopofosine I 131
Premium
The Fly
Cellectar announces U.S. FDA granted BTD for iopofosine I 131
13d ago
CLRB
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
Premium
Weekend Updates
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
1M ago
FL
MRK
Cellectar Biosciences Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Cellectar Biosciences Earnings Call: Progress Amid Challenges
1M ago
CLRB
Cellectar Biosciences downgraded to Hold from Buy at Maxim
PremiumThe Fly
Cellectar Biosciences downgraded to Hold from Buy at Maxim
1M ago
CLRB
Cellectar Biosciences Reports Q1 2025 Financials and Strategic Plans
PremiumCompany Announcements
Cellectar Biosciences Reports Q1 2025 Financials and Strategic Plans
1M ago
CLRB
Cellectar Biosciences reports Q1 EPS (14c), consensus (16c)
PremiumThe Fly
Cellectar Biosciences reports Q1 EPS (14c), consensus (16c)
1M ago
CLRB
Cellectar Biosciences expects cash to fund operations in Q4 of 2025
PremiumThe FlyCellectar Biosciences expects cash to fund operations in Q4 of 2025
1M ago
CLRB
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CLRB
Cellectar Biosciences announces plan to explore strategic alternatives
Premium
The Fly
Cellectar Biosciences announces plan to explore strategic alternatives
2M ago
CLRB
Cellectar Biosciences Enhances CEO and COO Severance Benefits
PremiumCompany Announcements
Cellectar Biosciences Enhances CEO and COO Severance Benefits
3M ago
8K
CLRB
Cellectar Biosciences: Promising Future with FDA Clarity and Innovative Radiopharmaceutical Advancements
PremiumRatings
Cellectar Biosciences: Promising Future with FDA Clarity and Innovative Radiopharmaceutical Advancements
3M ago
CLRB
Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings
PremiumCompany Announcements
Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings
3M ago
CLRB
Cellectar Biosciences Advances Cancer Drug Pipeline
PremiumCompany Announcements
Cellectar Biosciences Advances Cancer Drug Pipeline
3M ago
CLRB
Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges
PremiumCompany AnnouncementsCellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges
3M ago
CLRB
Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
Premium
The Fly
Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
3M ago
CLRB
Cellectar Biosciences sees cash runway into 4Q25
Premium
The Fly
Cellectar Biosciences sees cash runway into 4Q25
3M ago
CLRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >